The shingles vaccine is up to 97% effective in preventing the condition caused by the herpes zoster virus, which inflames nerves and causes painful rashes. Now, a new metastudy says it may also be a big help in boosting cardiovascular health.

In reaching this conclusion, the metastudy – which was carried out by Charles Williams, from the biopharma research company, GSK – looked at 19 different previous studies examining health metrics and the vaccine. He found that the shingles vaccine was associated with a 16% reduction in the risk of cardiac events, including stroke and heart attack in adults over the age of 50, and an 18% reduction in risk for adults between the age of 18 and 50.

https://newatlas.com/heart-disease/shingles-vaccine-cardiovascular/

Why should we care? As more and more evidence is found that herpesviruses have additional impact beyond the obvious direct "skin conditions", more medical and research attention should be directed their way.